{"id":"W2007680892","doi":"10.1136/bmj.f5133","title":"Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis","year":2013,"lang":"en","type":"review","venue":"BMJ","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa; Heart and Stroke Foundation of Canada","keywords":"Medicine; Apixaban; Rivaroxaban; Placebo; Dabigatran; Odds ratio; Meta-analysis; Warfarin; Internal medicine; Confidence interval; Vitamin K antagonist; Aspirin; Atrial fibrillation; Alternative medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02399221,0.003347417,0.02465863,0.01120422,0.0006994545,0.004046864,0.002417545,0.002564775,0.003459024],"category_scores_gemma":[0.0612636,0.001700508,0.04054864,0.01009825,0.0008129214,0.002135727,0.001893865,0.00179355,0.0003165561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003827893,"about_ca_system_score_gemma":0.004460287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006162102,"about_ca_topic_score_gemma":0.01243807,"domain_scores_codex":[0.9777195,0.01158953,0.005758579,0.00178968,0.002720902,0.0004217418],"domain_scores_gemma":[0.9641102,0.02577518,0.005962502,0.0009157582,0.002926049,0.0003103527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001126297,0.00002054561,0.002626464,0.3252302,0.6624944,0.00007678285,0.00005490867,0.0004672479,0.0001074598,0.0001032801,0.0003818803,0.007310489],"study_design_scores_gemma":[0.0004544616,0.0001554213,0.0021997,0.02559374,0.9701569,0.0000822607,0.00002787685,0.000192651,0.00007879078,0.0001545224,0.0008848567,0.00001883673],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004174367,0.993234,0.0006935453,0.0002201548,0.0002195949,0.0005317546,0.0006100718,0.0000242546,0.0002923146],"genre_scores_gemma":[0.1487907,0.841933,0.003714762,0.0008824369,0.0004609491,0.00274526,0.001084227,0.00003830916,0.0003504643],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02465863,"threshold_uncertainty_score":0.1268845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0911175371654379,"score_gpt":0.3849477009097608,"score_spread":0.2938301637443229,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}